Applied dna announces fourth quarter fiscal year 2023 financial results

- conference call/webcast scheduled for today at 4:30 pm et - stony brook, ny / accesswire / december 7, 2023 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in pcr-based dna technologies, today announced consolidated financial results for its fourth quarter ended september 30, 2023. "our fiscal fourth quarter concludes a productive year during which we took a number of critical steps that place us firmly in the execution phase of our pivot to a biotherapeutic manufacturing-first growth strategy," stated dr. james a.
APDN Ratings Summary
APDN Quant Ranking